Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy

Seminars in Immunology(2020)10.1016/j.smim.2020.101391Source: DataRank Database

MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy is a research paper published in Seminars in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 58 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access58 citations

Download PDF

Cite:

Linked data & code

uniprot nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.09)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Sushil Kumar ORCID,Vi Dam ORCID,Dario Ghersi ORCID,Maneesh Jain ORCID,Surinder K. Batra ORCID

Live enrichment

PubMed:31952903 PMC:PMC7160012 OpenAlex:https://openalex.org/W2999236967

NCI NIH HHS

Grant: R01 CA195586

NCI NIH HHS

Grant: U01 CA200466

NCI NIH HHS

Grant: P01 CA217798

NCI NIH HHS

Grant: U01 CA210240

National Institutes of Health

FWCI

3.09

Citation Percentile

0.9%

Citation Trend

2019

2020

2021

2022

2023

2024

2025

2026

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7160012

publisherhttps://api.elsevier.com/content/article/PII:S1044532320300075?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1044532320300075?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.smim.2020.101391

Fields of Study

Immunotherapy and Immune ResponsesGlycosylation and Glycoproteins ResearchPancreatic and Hepatic Oncology ResearchAnimalsAntigens, NeoplasmCancer VaccinesComputational BiologyEpitopesHumansImmunotherapyMucin-4MutationPancreatic NeoplasmsT-Lymphocytes

MeSH Terms

AnimalsEpitopesAntigens, NeoplasmHumansImmunotherapyMutationPancreatic NeoplasmsT-LymphocytesComputational BiologyCancer VaccinesMucin-4

Keywords

ImmunotherapyAntigenCancer immunotherapyImmunologyEpitopeImmunogenicityCancer vaccineCancer researchMedicineImmune systemBiologyVaccineNeoantigenPancreatic cancerMuc4

Sustainable Development Goals

SDG 0: Good health and well-being